Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Patent CN120484042B reveals a 5-step HE3286 synthesis route offering significant cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply chain reliability.
Novel 9,11-epoxy route reduces steps and cost for fluorometholone manufacturing. Reliable supplier for high-purity steroid intermediates.
Novel synthesis route for pharmaceutical intermediates reducing costs and improving supply chain reliability for global buyers seeking high purity materials.
Patent CN107353221B reveals Pd-catalyzed chiral amide synthesis offering high conversion rates and supply chain stability for global pharmaceutical intermediates manufacturing.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN110845305A details a novel organoaluminum catalyst for high-yield L-menthol production, offering significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN109796349A introduces a safe iron-catalyzed reduction method offering significant cost reduction and supply chain reliability for high-purity aromatic amine manufacturing.
Novel catalytic hydrogenolysis route improves yield and purity of 2-hydrazinopyridine derivatives, offering cost-effective supply chain solutions.
Discover the novel preparation method for Saxagliptin Intermediate A via patent CN111170927B. Achieve high purity and cost reduction in pharmaceutical manufacturing with our advanced process.
Patent CN102603822B details a novel alumina chromatography method reducing Acarbose Impurity A below 0.6% with yields exceeding 88.95%, offering significant cost and supply chain advantages.
Patent CN104829565B reveals iodine-catalyzed furanone synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes.
Patent CN106748826B details high-purity TMAEEA production. Offers supply chain reliability and cost efficiency for polyurethane manufacturers globally.
Patent CN113801203A details a stable chromatographic method for Caspofungin Acetate Impurity D. Achieve >95% purity for pharmaceutical quality control with scalable processes.
Patent CN103864877A reveals a high-yield Suzuki coupling route for Abiraterone Acetate, offering significant cost reduction and greener manufacturing for pharmaceutical intermediates.
Patent CN101805389A details a novel 3-step semi-synthetic route for Corosolic Acid from Ursolic Acid, offering >98% purity and significant cost reduction for pharmaceutical manufacturing.
Patent CN113173877A details a novel one-pot synthesis of indole acetyl imino sulfone derivatives using atmospheric CO, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation route for indole derivatives. High yields, mild conditions, scalable process for pharmaceutical intermediates.
Advanced chiral synthesis of pregabalin via dibenzylamine intermediates. Reduces genotoxic risks and improves scalability for reliable API manufacturing supply chains.
Patent CN116874446B details a novel MOPSO-Na synthesis route offering high purity and recyclable solvents, ensuring cost reduction in pharmaceutical intermediate manufacturing.